. Total number of CLs decreased in all treated groups, while CL diameter decreased in G1 as compared to G4 (P<0.05). Estrus/ovulation and higher pregnancy rate of camel could be hormonally induced by CIDR insertion for 10 days and eCG injection on day 8 of CIDR insertion.
Introduction
Dromedary camels (one-humped) have been an important role as a source of meat and milk in Egypt. Low reproductive efficiency of the camel had been reported (Kaufmann, 2005), due to the short breeding season, long lactation period and generally only one calf is produced every two years for each female (Minoia et al., 1992).
Camels are seasonally polyestrous animals with estrous cycle differed from that in other farm animals. The estrous cycle in camel is characterized by three phases lasting 24-28 days (Shalash, 1987) with absence of the luteal phase (Al-Sobayil, 2003). These phases include follicular growth, existence of mature follicles (estrous period) and follicular atresia. The estrous period is longer up to up to 8 days (Tibary and Anouassi, 1996). Ovulation in camel actually occurs mechanically by natural mating or induces by hormonal treatments (Al-Sobayil, 2003). The estrous signs in a female camel are characterized by the sitting of the camel to be mounted by other females, restlessness, frequent salivation, swelling of the vulva, vaginal mucous discharge, frequent urination (especially when the male comes close to her), and finally the acceptance of mating by the male (Homeida et al., 1988) .
Estrous synchronization for improving the reproductive performance is used in reproductive programs of most farm animals. Great attention of several researchers has been focused on different regimens of estrous synchronization in farm animals (Dahir et al., 1990; Elias et al., 1985). The progress in the methods of hormone extraction, purification and measurements of their concentrations in blood circulation has risen understanding the mechanisms of regulating reproduction in farm animals (Combarnous and Anouassi, 1994).
Understanding the hormonal changes throughout the estrous cycle of the she-camel extremely helped in the application of different hormonal combinations to induce and synchronize the estrus. As in other mammals, estrous synchronization in camels using hormonal treatments stimulates growth and development of the ovarian follicles and ovulation. In previous reports, estrous synchronization in the she-camel was based on the use of several hormones, including PMSG Estrus also could be synchronized in she-camel using hormonal combination including progesterone (P4) or its analogue either as daily injection or as an intra-vaginal releasing the device of PRID for a period of 10-20 days, followed by eCG injection (1500-2000 IU) 24 h before or on day of the device withdrawal (Tibary and Anouassi, 1997). However, estrous synchronization with timed artificial insemination (AI) in dromedary she-camels was carried out using hCG, Progesterone Release Intra-vaginal Device (PRID) for 17 days plus hCG or PRID plus eCG (Al-Sobayil, 2008). In addition, Controlled Intra-vaginal Drug Releasers (CIDR) proved to control ovarian activity in llama (Chaves et al., 2002) .
She-camel mostly does not ovulate without a natural mating or hormonal induction, and to reproductively manage a herd of she-camels, this requires laborious efforts of the owner and might result in incorrigible outcomes. Therefore, there existed a need for the estrus/ovulation synchronization of She-camels (Al-Sobayil, 2008). Most of the previous attempts are still missing a complete regimen for induction and synchronization of estrus in the she-camel, and of contraversing results.
To offer a new insight into estrous synchronization in she-camel during breeding season, the current study aimed to compare three hormonal protocols (GnRH+PGF 2 α, CIDR+eCG and eCG+PGF 2 α) for estrous synchronization in dromedary she-camel and consequently their effects on pregnancy rate by applying the natural insemination at the synchronized estrus.
II. Materials and Methods
This study was carried out at Center of Studies and Development of Camel Production, belonging to Animal Production Research Institute, Agricultural Research Center, Marsa Matrouh Governorate, Egypt, during the breeding season.
Animals:
Twenty eight sexually mature dromedary she-camels having 460-550 kg live body weight, 8-13 years old and 2-5 parities were used in this study. Animals were randomly divided into four similar groups, 7 animals in each. All animals were fed a daily basal diet consisting of 3.5 kg concentrate feed mixture (CFM), 2.5 kg clover hay (CH) and 2 kg rice straw (RS) per animal. Chemical analysis of CFM, BH and RS are shown in Table 1 . Ingredient of the CFM used in feeding all the experimental animals was composed of 25% wheat bran, 25% yellow corn, 9% un-corticated cotton seed meal, 20% barely, 15% rice brain, 3% molasses, 2% premix and 1% common salt. Experimental Groups: In this study, four similar experimental groups were used as the following: G1: Each animal was i.m. injected with 250 µg GnRH analogue (buserelin acetate; Receptal, Intervet International, Germany) on day 0, followed by 5 ml PGF 2 α (Intervet, B.V., Boxmer, Holland) on day 10, and animals in heat within 72 h of PGF 2 α injection were naturally inseminated. G2: Controlled Internal Drug Release (CIDR) containing 1.9 g of progesterone (EAZI-BREED CIDRTM, Interag, Hamilton, New Zealand) was intravaginally inserted in each animal on day 0, followed by injection of 1000 IU eCG (Synncropart, Ceva Sante Animal, France) on day 8. CIDR was removed on day 10 and then animals in heat were naturally inseminated within 72-120 h of CIDR withdrawal. The CIDR was inserted by restraining the female camel in a regular chute and the vulva was cleaned, disinfected and lubricated. The device was loaded into the applicator and gently was inserted into the vagina leaving a free portion of the string outside the vulva to facilitate its withdrawal. G3: Each animal was i.m. injected with 1000 IU eCG on day 0, followed by 5 ml PGF 2 α injection on day 10 and natural insemination of animals in heat within 72 h of PGF 2 α injection. G4: Animals were left without hormonal treatment and saved as control.
Estrus and Conception:
Animals in heat relative to total animals in each group were recorded to determine estrus rate. Also, time elapsed from the PGF2 injection (G1 and G3), CIDR withdrawal (G2) or start of treatment (G4) to estrus and mating was calculated. All inseminated animals were diagnosed for pregnancy on day 20-40 of mating using ultrasonographic examination to determined pregnancy rate based on total number of animals or number of inseminated animals in each group.
Statistical Analysis
Data were collected and statically analyzed by using the General Linear Model (GLM) procedures of the statistical Analysis Systems (SAS, 2004 ). Data obtained were tested by analysis of variance with one way design to test the group differences according to the following model: Yij = µ + P i + e ij ; where: Yij= observed values, µ= overall mean, P i = experimental group and e ij = Random error. Values were given as mean± standard error. All statements of significance were based on P<0.05 using Duncan's Multiple Range (Duncan, 1955).
III. Results And Discussion
Ovarian Follicles: Pre-treatment (Day 0), follicular diameter was higher (P<0.05) in G4 and G3 than in G2, which showed the lowest diameter, but these groups did not differ from that in G1 (Table 2 ). This means that camel in CIDR group showed the lowest diameter for all follicles and the largest follicles on both ovarian sides as compared other groups before treatment.
At the end of treatment (at mating), follicular diameter (for all follicles or largest follicles) was the highest (P<0.05) in G2 and G3, moderate in G4 and the lowest in G1 (Table 3) . Such trend of change in follicular diameter at mating in comparing with at 0 day may indicate pronounced effect of CIDR or eCG treatment on follicular growth and development more than of OvSynch protocol.
Pre-treatment (0 day), there were insignificant differences in the follicular diameter between pregnant and non-pregnant camels in each group or overall for all groups. However, at mating, diameter of largest or all visible follicles on both ovarian sides was wider (P<0.05) wider in pregnant than in non-pregnant camels in all groups. This trend was nearly observed within each group (Table 3) .
It is of interest to note that follicular growth was evident on the ovaries of untreated camels (G1) on 0 day or at mating in most camels with clearly mature follicles. Similar findings were observed in control camels during breeding season in September and October It is worth noting that mature follicles were seen on day 0 (the largest diameter of about 8 mm) and at mating (the largest diameter of 8-10.9 mm), particularly on the left ovaries in all groups. In camel administrated with 2000 IU of eCG or an OvSynch protocol (GnRH+PGF2α+GnRH on 0, 7 and 9 days), a high proportion of eCG treated and OvSynch treated camels evidenced a mature follicle on day 8 and 12 of treatment, respectively 
Estrus Rate:
All treated and control camels exhibited estrous activity at different times after the end of treatment for each group. Time of estrus incidence and subsequently of mating after the end of each treatment was longer (P<0.05) in G4 (control) than in treated groups, being the shortest in G2 as compared to G1 and G3.Overall mean of Time of estrus/mating was shorted (P<0.05) shorter in pregnant than in non-pregnant of all groups and this trend was recorded within each group (Tables 4 and 5 ). In comparable with the present results, different rates and times of estrus incidence were recorded by Al-Sobayil (2008) for she-camel treated with eCG+hCG (T1); and PRID for 17 days and hCG (G2) or eCG (G3) at the time of device removal. Estrus rate was 20, 40 and 100% during breeding season, respectively. The estrous exhibition started 24 hours after the device removal and after the hCG injection. In accordance with the present results, the later author indicated that synchronizing female camels with progestagen in addition to the administration of an ovulatory hormone may result in a better estrous exhibition within a narrower period. Also, 
Hormonal Profile:
The differences in overall mean of P 4 concentration between groups were not significant pre-treatment, at mating and on day 70 post-mating; however, there was a marked increase in P 4 concentration at mating Overall mean of E 2 concentration pre-treatment increased (P<0.05) in G3 and decreased (P<0.05) in G1, while did not differ in G2 as compared to G4. At mating, E 2 concentration increased (P≤0.05) in G1 and G2 and decreased (P<0.05) in G3 as compared to G4. This means that OvSynch protocol and CIDR markedly increased E 2 concentration, while eCG decreased E 2 concentration at mating compared with pre-treatment (Table 6 ). Of course the trend of change in E 2 level is in relation with follicular size. In this respect, Derara et al. (2014) showed that serum E 2 peaked when a large follicle was detected on day 8.5±2.8 post-GnRH treatment, concluding that dromedary camels are highly responsive to early GnRH treatment.
On day 70 post-mating, E 2 concentration was lower (P<0.05) in all treated groups than in control one, showing inconsistent trend of changes at different sampling times ( Table 7) . The observed increase in overall E2 concentration in OvSynch and CIDR after the end of treatment (at mating) may suggest initiation of new follicular wave after CL regression by PGF2α in OvSynch group and CIDR removal in CIDR group. In this respect, Ismail et al. (1998) found that PGF2α injection into a she-camel primed with hCG (having functioning CL) during the breeding season induced an increase in plasma estradiol-17β on day 5 post-injection as compared to that pre-treatment. Also, Hussein et al. (2015) reported that the overall E 2 profile after CIDR application for 10 days was higher than that after CIDR application for 7 and 14 days, respectively during breeding season. On the other hand, Chaves et al. (2002) reported that E 2 concentration in IIama decreased drastically by day one post-insertion of CIDR and remain low until day 6, when they started to increase again. In addition, these results suggested that the use of exogenous P 4 did not synchronize wave emergence in camels as follicular waves continued to emerge during the period of treatment. Overall concentration of P 4 pre-treatment was similar in pregnant and non-pregnant camels, reflecting different reproductive statuses of camels within each group before treatment. At mating, overall P 4 concentration was lower (P<0.05) in pregnant (≤0.05 ng/ml) than in non-pregnant (≥1 ng/ml) ( Table 6 ). This trend was noticed (1998) found that PGF2α injection into a she-camel primed with hCG (having functioning CL) during the breeding season significantly decreased P4 level on days 1 and 2 post-injection. Also, they observed increase in plasma P4 to 1.0 µg/ml four days post-hCG injection, reaching its maximum level on day 8 post-injection. On day 70 post-mating, overall mean of P4 concentration was higher (P<0.05) in pregnant than in nonpregnant animals, ranging from 4.366 to 8.894 µg/ml in pregnant camels in all groups (Table 6 ). Several authors reported that Plasma P 4 concentrations recorded in pregnant camels varied from 1.40 to 6.45 ng/ml (Agarwal et  al., 1987& 1997) . In pregnant camels, P 4 values are above 1 µg/ml on day 20 post-mating (Dholpuria et al.,  2012) or varied from 1.40 to 6.45 ng/ml (Agarwal et al., 1987& 1997) . However, Quzy et al. (2013) considered camels with P4 values between 1-2 ng/ml as doubtful because of the possibility of early embryonic deaths (Dholpuria et al., 2012) . This trend was more pronounced in CIDR and eCG groups as a result of increasing pregnancy rate of these groups as compared to other groups.
On the other hand, overall concentration of E 2 was higher (P<0.05) in non-pregnant than in pregnant animals only on day 70 post-mating, reflecting higher ovarian activity in non-pregnant animals during this time in all groups, except for those in OvSynch group (Table 7) .
Generally, there was a marked relationship between P 4 and E 2 , in particular at mating, whereas P 4 showed the lowest levels versus the highest E 2 levels. The correlation between the plasma P 4 and E 2 levels augments the hypothesis that luteolysis can be induced within 2-4 days and mature follicles can be palpated 3-5 days posts PGF2α injection (Ismail et al., 1998) . Some studies have shown that there is a sharp decline in P 4 after luteolysis in camel and mature ovulatory sized follicles are present on the ovaries within 4 to 5 days of treatment (Ismail et al., 1998).
Pregnancy Rate:
Pregnancy rate of synchronized camels was the highest (85.71%, P<0.05) in G2, followed by G3 (71.43%) and G1 (57.14%), while G1 showed the lowest pregnancy rate (42.86%, P<0.05). These results indicated significant improvement of camel fertility in all treated groups as compared to control one, being the best in camels treated with CIDR plus eCG, followed by those treated with eCG and PGF2α ( Table 8 ). The physiological explanation for this increase may be attributed to that the eCG molecule has FSH-like activity which might have enhanced the follicular development accelerating the existence of the dominant follicle and subsequently causing ovulation via its LH-like action (Al-Sobayil, 2008). In accordance with the present results, Al-Sobayil (2008) found that the highest calving rate (80%) was achieved when PRID was followed by eCG. This result agreed with that obtained earlier by Simpkin (1987) when a 15-day progestogen treatment followed by the administration of 1500-2500 IU eCG. The later authors reported that an eCG dose guarantees the presence of mature follicle(s) and subsequent ovulation. Also, Tibary and Anouassi (2000) reported that the synchronization of follicular development and ovulation is improved by the administration of 1500-2000 IU eCG one day before the PRID removal, or the last day of progestogen treatment. In comparable with the present rates of pregnancy, Quzy et al. (2013) found that lower pregnancy rates than that reported in our study, being 50.0, 65.11 and 61.53% in control, eCG (2000 IU) and OvSynch treated camels, respectively.
It is of interest to note that the effect of hormonal treatment on camel fertility was associated with significant effect on number and diameter of CL of pregnant camels. Total number of CL per animal decreased (P<0.05) in all treated groups, while CL diameter decreased (P<0.05) decreased in OvSynch group only as compared to control one (Table 9 ). Shalash (1965) and Elias et al. (1984) reported that CL could be palpated 8-10 days post mating. 
IV. Conclusion
Administration of eCG (1000 IU), as it contains mainly the FSH-like activity and partially the LH-like activity, 48 h prior to CIDR insertion for 10 days or 10 days prior to PGF2α injection, caused a better synchrony of estrus and ovulation, and improved pregnancy rate of camels. For achieving an appropriate estrous synchronization of dromedary camels during breeding season, the estrus and ovulation could be hormonally induced by CIDR insertion for 10 days and eCG injection on day 8 (48 h before CIDR withdrawal) with the highest pregnancy rate. The use of OvSynch did not exceed the pregnancy rate. Further studies are needed to monitor the failure of OvSynch protocol to improve fertility of she-camels during breeding season.
